Cargando…
ANGI-05 PATHOGENESIS OF RESISTANCE (MIMICRY AND CO-OPTION) TO ANTI-ANGIOGENIC TREATMENT FOR GLIOBLASTOMA
PURPOSE: Vessel co-option and vascular mimicry are important resistant factors with ant-angiogenic treatment for glioblastoma, but those precise evaluation is not clear. We had three types of glioblastoma surgically removed specimens treated with / without bevacizumab (Bev). Using these samples, pat...
Autores principales: | Takano, Shingo, Tanaka, Toshihide, Ishikawa, Eiichi, Yamamoto, Youhei, Takai, Jun, Matsuda, Masahide, Tsurubuchi, Takao, Akutsu, Hiroyoshi, Matsumura, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213377/ http://dx.doi.org/10.1093/noajnl/vdz039.020 |
Ejemplares similares
-
Maximum resection and immunotherapy improve glioblastoma patient survival: a retrospective single-institution prognostic analysis
por: Ishikawa, Eiichi, et al.
Publicado: (2021) -
GCT-38. RELAPSE PATTERNS OF INTRACRANIAL GERMINOMAS BEFORE AND AFTER ENDOSCOPIC ERA
por: Tsurubuchi, Takao, et al.
Publicado: (2020) -
Combination of Palonosetron, Aprepitant, and Dexamethasone Effectively Controls Chemotherapy-induced Nausea and Vomiting in Patients Treated with Concomitant Temozolomide and Radiotherapy: Results of a Prospective Study
por: MATSUDA, Masahide, et al.
Publicado: (2016) -
Symptomatic Remote Cyst after BCNU Wafer Implantation for Malignant Glioma
por: MATSUMURA, Hideaki, et al.
Publicado: (2018) -
Timing of bevacizumab administration after biopsy for unresectable newly diagnosed glioblastoma
por: Matsuda, Masahide, et al.
Publicado: (2022)